Xponance’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Buy |
40,923
+790
| +2% | +$28.5K | 0.01% | 607 |
|
|
2025
Q1 | $1.25M | Buy |
40,133
+1,437
| +4% | +$44.7K | 0.01% | 622 |
|
|
2024
Q4 | $987K | Buy |
38,696
+5,402
| +16% | +$138K | 0.01% | 728 |
|
|
2024
Q3 | $942K | Buy |
33,294
+1,590
| +5% | +$45K | 0.01% | 722 |
|
|
2024
Q2 | $836K | Buy |
31,704
+606
| +2% | +$16K | 0.01% | 731 |
|
|
2024
Q1 | $944K | Buy |
31,098
+17,583
| +130% | +$534K | 0.01% | 740 |
|
|
2023
Q4 | $380K | Sell |
13,515
-4,703
| -26% | -$132K | ﹤0.01% | 1012 |
|
|
2023
Q3 | $494K | Buy |
18,218
+5,090
| +39% | +$138K | 0.01% | 896 |
|
|
2023
Q2 | $404K | Sell |
13,128
-15
| -0.1% | -$461 | 0.01% | 970 |
|
|
2023
Q1 | $474K | Buy |
13,143
+63
| +0.5% | +$2.27K | 0.01% | 931 |
|
|
2022
Q4 | $517K | Buy |
13,080
+5,972
| +84% | +$236K | 0.01% | 885 |
|
|
2022
Q3 | $286K | Buy |
7,108
+153
| +2% | +$6.16K | 0.01% | 1007 |
|
|
2022
Q2 | $292K | Sell |
6,955
-16,442
| -70% | -$690K | 0.01% | 1015 |
|
|
2022
Q1 | $912K | Buy |
23,397
+222
| +1% | +$8.65K | 0.02% | 626 |
|
|
2021
Q4 | $924K | Buy |
23,175
+381
| +2% | +$15.2K | 0.01% | 638 |
|
|
2021
Q3 | $824K | Sell |
22,794
-1,378
| -6% | -$49.8K | 0.02% | 654 |
|
|
2021
Q2 | $991K | Buy |
24,172
+9,793
| +68% | +$401K | 0.02% | 600 |
|
|
2021
Q1 | $627K | Buy |
14,379
+9,640
| +203% | +$420K | 0.01% | 674 |
|
|
2020
Q4 | $237K | Buy |
+4,739
| New | +$237K | 0.01% | 1007 |
|